Daniel Thomas

发表

Outcomes and health care utilization of older patients with acute myeloid leukemia.

A. Wei, I. Lewis, S. Edwards, 2020, Journal of geriatric oncology.

international cohort Antiretroviral use and other risks for HIV-associated neuropathies in an

S. Wesselingh, J. McArthur, P. Hauer, 2008 .

JAK2 Alterations in Acute Lymphoblastic Leukemia: Molecular Insights for Superior Precision Medicine Strategies

S. Heatley, J. Bruning, D. White, 2022, Frontiers in Cell and Developmental Biology.

Persistence of myelofibrosis treated with ruxolitinib: biology and clinical implications

J. Babon, D. Tvorogov, D. Ross, 2021, Haematologica.

Targeted gene panels identify a high frequency of pathogenic germline variants in patients diagnosed with a hematological malignancy and at least one other independent cancer

Anna L. Brown, Paul P. S. Wang, Soma Das, 2021, Leukemia.

Human gene-engineered calreticulin mutant stem cells recapitulate MPN hallmarks and identify targetable vulnerabilities

A. Reinisch, S. Trajanoski, C. Waskow, 2023, Leukemia.

TP53 mutation variant allele frequency of ≥10% is associated with poor prognosis in therapy-related myeloid neoplasms

Anna L. Brown, H. Scott, A. Tefferi, 2023, Blood Cancer Journal.

TP53 mutation in therapy-related myeloid neoplasm defines a distinct molecular subtype.

Anna L. Brown, A. Wei, H. Scott, 2022, Blood.

Mitochondrial translocation of TFEB regulates complex I and inflammation

S. Pitson, H. Nolte, M. Pitman, 2023, bioRxiv.

Machine learning finds new AML subtypes.

Daniel Thomas, 2021, Blood.

A Personalized Risk Model for Azacitidine Outcome in Myelodysplastic Syndrome and Other Myeloid Neoplasms Identified by Machine Learning Model Utilizing Real-World Data

C. Kok, D. Yeung, D. Ross, 2023, Cancers.